Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
18th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Special Features
Special Features
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
2016
2014
2013
2012
2011
2010
2009
2008
2007
2006
22-May-2009
Edition 312 - Positive Results for Peplin’s Phase III Actinic Keratoses Trial
15-May-2009
Edition 311 - Stellar Performance by Leading Australian Biotech Stocks for Start of 2009
8-May-2009
Edition 310 - Excellent Result For Pharmaxis Phase III Cystic Fibrosis Trial
1-May-2009
Edition 309 - How Many Millions Of Lives Will These Three Australians Save?
24-Apr-2009
Edition 308 - Prima Biomed Back in the Spotlight
17-Apr-2009
Edition 307 - Late Stage Biotechs Attract Strong Investor Interest
3-Apr-2009
Edition 306 - A Gain For The Quarter But Funding For Biotech Looks Bleak
27-Mar-2009
Edition 305 - A Model Emerges on How to Build Successful Diagnostic Companies
20-Mar-2009
Edition 304 - Battle for Cash Assets in Non-Performing Biotechs not Exclusive to Australia
13-Mar-2009
Edition 302 - Alchemia's Partner Files ANDA As A Share Market Rally Starts
Previous
1
2
3
4
5
Next